---
title: "ASCO26: BMS and J&J debut shining multiple myeloma data"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288303824.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-06-01T10:49:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288303824.md)
  - [en](https://longbridge.com/en/news/288303824.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288303824.md)
---

# ASCO26: BMS and J&J debut shining multiple myeloma data

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)

## Related News & Research

- [J&J secures extended NICE approval for Darzalex following earlier refusal](https://longbridge.com/en/news/289161015.md)
- [FACTBOX-Major deals involving US drugmakers and biotechs over the past decade](https://longbridge.com/en/news/289163903.md)
- [How Is Royal Caribbean Cruises' Stock Performance Compared to Other Consumer Discretionary Stocks](https://longbridge.com/en/news/289174213.md)
- [RTX invests $100 million to accelerate radar testing and interceptor production in Rhode Island | RTX Stock News](https://longbridge.com/en/news/289067531.md)
- [Shift in biosimilar commercial landscape essential for sector sustainability, expert says](https://longbridge.com/en/news/289174897.md)